Keyphrases
Parkin
100%
MALDI-TOF Mass Spectrometry
100%
High-throughput Screening Platform
100%
In Vitro Activity
22%
Parkinson's Disease
11%
Protein Kinase
11%
Gain-of-function mutation
11%
High-throughput
11%
E3 Ubiquitin Ligase
11%
Small Molecules
11%
Ubiquitylation
11%
Accurate Quantification
11%
E3 Ligase Activity
11%
Patient Prognosis
11%
Pharmacological Treatment
11%
Mitochondrial Dysfunction
11%
Therapeutic Approaches
11%
Platform-Based
11%
Primary Screening
11%
Parkinson Patients
11%
Idiopathic Parkinson's Disease
11%
Lysine Residue
11%
Ubiquitin Conjugation
11%
Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS)
11%
PTEN-induced Kinase 1 (PINK1)
11%
Mitophagy
11%
Postural Instability
11%
Bradykinesia
11%
Non-motor Symptoms
11%
Balanced Loss Function
11%
Autonomic Abnormalities
11%
Progressive Neurological Disease
11%
Complementary Matrices
11%
High-throughput Platform
11%
Rest Tremor
11%
Pharmacology, Toxicology and Pharmaceutical Science
High-Throughput Screening
100%
Parkin
100%
Parkinson's Disease
33%
Neurologic Disease
11%
Phosphotransferase
11%
Protein Kinases
11%
Ligase
11%
Ubiquitin
11%
Ubiquitin Protein Ligase E3
11%
Lysine
11%
Matrix-Assisted Laser Desorption/Ionization
11%
Bradykinesia
11%